(Q28206154)

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522010

16 March 2024

S. P. Whalen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522010

16 March 2024

L. M. Sandoval

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522010

16 March 2024

G. Lynch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522010

16 March 2024

C. M. Gall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522010

full work available at URL

16 March 2024

language of work or name

English

0 references

publication date

2003

0 references

https://api.elsevier.com/content/article/PII:S0306452203004238?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00423-8

https://api.elsevier.com/content/article/PII:S0306452203004238?httpAccept=text/plain

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00423-8

16 March 2024

0 references

121

0 references

issue

2

0 references

page(s)

509-21

0 references

cites work

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Functional recovery after brain lesion--contralateral neuromodulation: an fMRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Basal ganglia: functional anatomy and physiology. Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

The use of c-fos as a metabolic marker in neuronal pathway tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Neuronal activity and tonotopy in the auditory system visualized by c-fos gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Mapping brain networks engaged by, and changed by, learning

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Imaging strategies in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Odor-induced increases in c-fos mRNA expression reveal an anatomical "unit" for odor processing in olfactory bulb

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Activation of c-fos in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Differential patterns of c-fos mRNA expression in amygdala during successive stages of odor discrimination learning

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Changes in c-fos mRNA expression in rat brain during odor discrimination learning: differential involvement of hippocampal subfields CA1 and CA3.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Regional patterns of c-fos mRNA expression in rat hippocampus following exploration of a novel environment versus performance of a well-learned discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAM

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Enhancement by an ampakine of memory encoding in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Brain imaging of affective disorders and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Facilitation of olfactory learning by a modulator of AMPA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Chronic methamphetamine intoxication model of schizophrenia in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Role of ion flux in the control of c-fos expression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Stimulus-transcription coupling in neurons: role of cellular immediate-early genes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

The regulation and function of c-fos and other immediate early genes in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

[Modification of the behavioral effects of drugs after repeated administration--special reference to the reverse tolerance of amphetamines]

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Glutamate: a new target in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Prefrontal function in schizophrenia: confounds and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Plasticity of primary somatosensory cortex paralleling sensorimotor skill recovery from stroke in adult monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900423-8

7 January 2021

Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus

5

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00423-8

Synergistic interactions between ampakines and antipsychotic drugs

16 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00423-8

Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat

16 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00423-8

16 March 2024

Identifiers

0 references